{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:11:34Z","timestamp":1788865894298,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-14039-2","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:04:24Z","timestamp":1784631864000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Viral load suppression and associated factors following enhanced adherence counseling among people living with HIV\/AIDS"],"prefix":"10.1186","volume":"26","author":[{"given":"Teshome","family":"Nadew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadesse Mamo","family":"Dejene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraraw","family":"Gebre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abinet","family":"Dagnaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akine","family":"Eshete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"14039_CR1","doi-asserted-by":"crossref","unstructured":"Anito AA, Lenjebo TL, Woticha E, Solomon F. Magnitude of viral load suppression and associated factors among clients on antiretroviral therapy in public hospitals of Hawassa City Administration, Ethiopia. HIV AIDS (Auckl). 2022;14:529.","DOI":"10.2147\/HIV.S387787"},{"key":"14039_CR2","doi-asserted-by":"crossref","unstructured":"Atnafu GT, Moges NA, Wubie M, Gedif G. Incidence and predictors of viral load suppression after enhanced adherence counseling among HIV-positive adults in West Gojjam Zone, Amhara Region, Ethiopia. Infect Drug Resist. 2022;15:261\u201374.","DOI":"10.2147\/IDR.S341392"},{"issue":"1","key":"14039_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4102\/sajhivmed.v18i1.776","volume":"18","author":"G Meintjes","year":"2017","unstructured":"Meintjes G, Moorhouse MA, Carmona S, Davies N, Dlamini S, Van Vuuren C, et al. Adult antiretroviral therapy guidelines 2017. South Afr J HIV Med. 2017;18(1):1\u201324.","journal-title":"South Afr J HIV Med"},{"issue":"1","key":"14039_CR4","first-page":"8909232","volume":"2020","author":"G Diress","year":"2020","unstructured":"Diress G, Dagne S, Alemnew B, Adane S, Addisu A. Viral load suppression after enhanced adherence counseling and its predictors among high viral load HIV seropositive people in north wollo zone public hospitals, northeast Ethiopia, 2019: retrospective cohort study. AIDS Res Treat. 2020;2020(1):8909232.","journal-title":"AIDS Res Treat"},{"issue":"1","key":"14039_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12981-025-00745-5","volume":"22","author":"Y Chen","year":"2025","unstructured":"Chen Y, Li AD, Yang Y, Lu J, Xu Y, Ji X, et al. Global, regional and national burden of HIV\/AIDS among individuals aged 15\u201379 from 1990 to 2021. AIDS Res Ther. 2025;22(1):51.","journal-title":"AIDS Res Ther"},{"issue":"1","key":"14039_CR6","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1186\/s12889-025-23121-4","volume":"25","author":"Y Lu","year":"2025","unstructured":"Lu Y, Li H, Dong R, Zhang M, Dong X, Yang C, et al. Global and regional disease burden of HIV\/AIDS from 1990 to 2021 and projections to 2030. BMC Public Health. 2025;25(1):1928.","journal-title":"BMC Public Health"},{"issue":"1","key":"14039_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.59298\/ROJPHM\/2024\/414752","volume":"4","author":"M Mark","year":"2024","unstructured":"Mark M. The International Problem of HIV\/AIDS in the Modern World: A Comprehensive Review of Political, Economic, and Social Impacts. Res Output J Public Health Med. 2024;4(1):47\u201352.","journal-title":"Res Output J Public Health Med"},{"key":"14039_CR8","doi-asserted-by":"crossref","unstructured":"Marsh K, Eaton JW, Mahy M, Sabin K, Autenrieth CS, Wanyeki I, et al. Global, regional and country-level 90-90-90 estimates for 2018: assessing progress towards the 2020 target. AIDS. 2019;33(Suppl 3):S213\u201326.","DOI":"10.1097\/QAD.0000000000002355"},{"key":"14039_CR9","unstructured":"Organization WH. The advanced HIV disease research landscape. World Health Organization; 2024."},{"key":"14039_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ijid.2018.10.022","volume":"78","author":"Y Assefa","year":"2019","unstructured":"Assefa Y, Gilks CF, Dean J, Tekle B, Lera M, Balcha TT, et al. Towards achieving the fast-track targets and ending the epidemic of HIV\/AIDS in Ethiopia: successes and challenges. Int J Infect Dis. 2019;78:57\u201364.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"14039_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12981-024-00625-4","volume":"21","author":"WG Ayana","year":"2024","unstructured":"Ayana WG, Ayana Hordofa M, Dechasa Yadeta A. Determinants of virologic failure among adult HIV patients on first line antiretroviral treatment in Oromia, Central Ethiopia: 2022 a case-control study. AIDS Res Therapy. 2024;21(1):42.","journal-title":"AIDS Res Therapy"},{"issue":"9326","key":"14039_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0140-6736(02)09347-9","volume":"360","author":"D Wilson","year":"2002","unstructured":"Wilson D. HIV\/AIDS prevention and treatment. Lancet. 2002;360(9326):88\u20139.","journal-title":"Lancet"},{"key":"14039_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-021-00372-w","volume":"18","author":"A Pius","year":"2021","unstructured":"Pius A, Josephine NN, Erick S, Winifred A, Rita M, Silverjoseph O, et al. Influence of intensified adherence counselling on viral load suppression of people receiving antiretroviral therapy at a health centre IV in southwestern Uganda: a qualitative study. AIDS Res Therapy. 2021;18:1\u20137.","journal-title":"AIDS Res Therapy"},{"key":"14039_CR14","doi-asserted-by":"crossref","unstructured":"Mitiku AA, Dimore AL, Gach W. Trends of HIV infection and progress towards the 95-95-95 targets in Gambella Regional State from 2019 to 2023, southwest Ethiopia. HIV AIDS (Auckl). 2024;16:193\u2013201.","DOI":"10.2147\/HIV.S457550"},{"key":"14039_CR15","doi-asserted-by":"crossref","unstructured":"Kerschberger B, Boulle AM, Kranzer K, Hilderbrand K, Schomaker M, Coetzee D, et al. Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy. Afr J Reprod Gynaecol Endoscopy. 2015;18(1).","DOI":"10.7448\/IAS.18.1.20092"},{"issue":"01","key":"14039_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4236\/wja.2021.111001","volume":"11","author":"EW Isaac","year":"2021","unstructured":"Isaac EW, Ajani A, Difa AJ, Aremu JT, Oluwaseun OC, Hassan MD. Viral Suppression in Adult Nigerians in a Regional Antiretroviral Therapy Programme: A Cross Sectional Descriptive Study. World J AIDS. 2021;11(01):1\u201314.","journal-title":"World J AIDS"},{"key":"14039_CR17","doi-asserted-by":"crossref","unstructured":"Maheu-Giroux M, Ciaranello AL, Salomon JA, Sohn AH. Refining global HIV estimates for decision-making: advances in analytic and modelling methods used by the Joint United Nations Programme on HIV\/AIDS. J Int AIDS Soc. 2021;24(Suppl 5):e25790.","DOI":"10.1002\/jia2.25790"},{"key":"14039_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2471\/BLT.12.112946","volume":"91","author":"JH McMahon","year":"2013","unstructured":"McMahon JH, Elliott JH, Bertagnolio S, Kubiak R, Jordan MR. Viral suppression after 12 months of antiretroviral therapy in low-and middle-income countries: a systematic review. Bull World Health Organ. 2013;91:377\u201385.","journal-title":"Bull World Health Organ"},{"issue":"1","key":"14039_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4314\/ahs.v20i1.18","volume":"20","author":"DM Byonanebye","year":"2020","unstructured":"Byonanebye DM, Semitala FC, Katende J, Bakenga A, Arinaitwe I, Kyambadde P, et al. High viral suppression and low attrition in healthy HIV-infected patients initiated on ART with CD4 above 500 cells\/\u00b5L in a program setting in Uganda. Afr Health Sci. 2020;20(1):132\u201341.","journal-title":"Afr Health Sci"},{"issue":"5","key":"14039_CR20","doi-asserted-by":"publisher","first-page":"e0232703","DOI":"10.1371\/journal.pone.0232703","volume":"15","author":"M Abadiga","year":"2020","unstructured":"Abadiga M, Hasen T, Mosisa G, Abdisa E. Adherence to antiretroviral therapy and associated factors among Human immunodeficiency virus positive patients accessing treatment at Nekemte referral hospital, west Ethiopia, 2019. PLoS ONE. 2020;15(5):e0232703.","journal-title":"PLoS ONE"},{"key":"14039_CR21","unstructured":"Organization WH. Health in 2015: from MDGs, millennium development goals to SDGs, sustainable development goals. 2015."},{"key":"14039_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-4702-z","volume":"19","author":"JH Ali","year":"2019","unstructured":"Ali JH, Yirtaw TG. Time to viral load suppression and its associated factors in cohort of patients taking antiretroviral treatment in East Shewa zone, Oromiya, Ethiopia, 2018. BMC Infect Dis. 2019;19:1\u20136.","journal-title":"BMC Infect Dis"},{"key":"14039_CR23","doi-asserted-by":"crossref","unstructured":"Mogosetsi NJ, Mabuza LH, Ogunbanjo GA. The prevalence of HIV viral load suppression and related factors among patients on antiretroviral therapy at Phedisong 4 Clinic, Pretoria, South Africa. Open Public Health J. 2018;11(1).","DOI":"10.2174\/1874944501811010135"},{"key":"14039_CR24","doi-asserted-by":"crossref","unstructured":"Adeiza MA, Wachekwa I, Nuta C, Donato S, Koomson F, Whitney J, et al. Gaps and opportunities in HIV service delivery in high-volume HIV care centers in Liberia: lessons from the field. Ann Glob Health. 2021;87(1).","DOI":"10.5334\/aogh.3246"},{"key":"14039_CR25","doi-asserted-by":"crossref","unstructured":"Ford N, Orrell C, Shubber Z, Apollo T, Vojnov L. HIV viral resuppression following an elevated viral load: a systematic review and meta-analysis. J Int AIDS Soc. 2019;22(11).","DOI":"10.1002\/jia2.25415"},{"key":"14039_CR26","unstructured":"DRuGS A. tHe uSe of ANtIRetRoVIRAL DRuGS foR tReAtING AND PReVeNtING HIV INfeCtIoN. 2013."},{"key":"14039_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-3924-4","volume":"19","author":"M Ahmed","year":"2019","unstructured":"Ahmed M, Merga H, Jarso H. Predictors of virological treatment failure among adult HIV patients on first-line antiretroviral therapy in Woldia and Dessie hospitals, Northeast Ethiopia: a case-control study. BMC Infect Dis. 2019;19:1\u20137.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"14039_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S2055-6640(20)30466-0","volume":"2","author":"S Rangarajan","year":"2016","unstructured":"Rangarajan S, Colby DJ, Bui DD, Nguyen HH, Tou PB, Danh TT, et al. Factors associated with HIV viral load suppression on antiretroviral therapy in Vietnam. J virus eradication. 2016;2(2):94\u2013101.","journal-title":"J virus eradication"},{"key":"14039_CR29","first-page":"71","volume":"157","author":"E Erjino","year":"2023","unstructured":"Erjino E, Abera E, Lemma Tirore L. Time to Viral Load Suppression and Its Predictors Among Adult Patients on Antiretro Viral Therapy in Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital, Hossana, Southern Ethiopia. HIV\/AIDS-Research Palliat Care. 2023;157:71.","journal-title":"HIV\/AIDS-Research Palliat Care"},{"key":"14039_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-015-0056-9","volume":"12","author":"R Thapa","year":"2015","unstructured":"Thapa R, Amatya A, Pahari DP, Bam K, Newman MS. Nutritional status and its association with quality of life among people living with HIV attending public anti-retroviral therapy sites of Kathmandu Valley, Nepal. AIDS Res therapy. 2015;12:1\u201310.","journal-title":"AIDS Res therapy"},{"key":"14039_CR31","first-page":"117863372097063","volume":"13","author":"P Wakooko","year":"2020","unstructured":"Wakooko P, Gavamukulya Y, Wandabwa JN. Viral load suppression and associated factors among HIV patients on antiretroviral treatment in Bulambuli district, eastern Uganda: a retrospective cohort study. Infect Diseases: Res Treat. 2020;13:1178633720970632.","journal-title":"Infect Diseases: Res Treat"},{"issue":"12","key":"14039_CR32","doi-asserted-by":"publisher","first-page":"e25644","DOI":"10.1002\/jia2.25644","volume":"23","author":"AD Haas","year":"2020","unstructured":"Haas AD, Technau KG, Pahad S, Braithwaite K, Madzivhandila M, Sorour G, et al. Mental health, substance use and viral suppression in adolescents receiving ART at a paediatric HIV clinic in South Africa. J Int AIDS Soc. 2020;23(12):e25644.","journal-title":"J Int AIDS Soc"},{"key":"14039_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-13-617","volume":"13","author":"V Hansana","year":"2013","unstructured":"Hansana V, Sanchaisuriya P, Durham J, Sychareun V, Chaleunvong K, Boonyaleepun S, et al. Adherence to antiretroviral therapy (ART) among people living with HIV (PLHIV): a cross-sectional survey to measure in Lao PDR. BMC Public Health. 2013;13:1\u201311.","journal-title":"BMC Public Health"},{"issue":"15","key":"14039_CR34","doi-asserted-by":"publisher","first-page":"e3361","DOI":"10.1097\/MD.0000000000003361","volume":"95","author":"WM Bezabhe","year":"2016","unstructured":"Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. Adherence to antiretroviral therapy and virologic failure: a meta-analysis. Medicine. 2016;95(15):e3361.","journal-title":"Medicine"},{"key":"14039_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-017-2428-3","volume":"17","author":"L Bulage","year":"2017","unstructured":"Bulage L, Ssewanyana I, Nankabirwa V, Nsubuga F, Kihembo C, Pande G, et al. Factors associated with virological non-suppression among HIV-positive patients on antiretroviral therapy in Uganda, August 2014\u2013July 2015. BMC Infect Dis. 2017;17:1\u201311.","journal-title":"BMC Infect Dis"},{"key":"14039_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijid.2020.05.097","volume":"97","author":"E Maina","year":"2020","unstructured":"Maina E, Mureithi H, Adan A, Muriuki J, Lwembe R, Bukusi E. Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya. Int J Infect Dis. 2020;97:151\u20138.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"14039_CR37","doi-asserted-by":"publisher","first-page":"1947566","DOI":"10.1080\/16549716.2021.1947566","volume":"14","author":"S Lakoh","year":"2021","unstructured":"Lakoh S, Jiba DF, Vandy AO, Poveda E, Adekanmbi O, Murray MJ, et al. Assessing eligibility for differentiated service delivery, HIV services utilization and virologic outcomes of adult HIV-infected patients in Sierra Leone: a pre-implementation analysis. Global health action. 2021;14(1):1947566.","journal-title":"Global health action"},{"issue":"16","key":"14039_CR38","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1097\/QAD.0000000000000438","volume":"28","author":"T Duong","year":"2014","unstructured":"Duong T, Judd A, Collins IJ, Doerholt K, Lyall H, Foster C, et al. Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland. Aids. 2014;28(16):2395\u2013405.","journal-title":"Aids"},{"issue":"2","key":"14039_CR39","doi-asserted-by":"publisher","first-page":"e0211326","DOI":"10.1371\/journal.pone.0211326","volume":"14","author":"T Bvochora","year":"2019","unstructured":"Bvochora T, Satyanarayana S, Takarinda KC, Bara H, Chonzi P, Komtenza B, et al. Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: operational issues. PLoS ONE. 2019;14(2):e0211326.","journal-title":"PLoS ONE"},{"issue":"10","key":"14039_CR40","doi-asserted-by":"publisher","first-page":"e25194","DOI":"10.1002\/jia2.25194","volume":"21","author":"D Etoori","year":"2018","unstructured":"Etoori D, Ciglenecki I, Ndlangamandla M, Edwards CG, Jobanputra K, Pasipamire M, et al. Successes and challenges in optimizing the viral load cascade to improve antiretroviral therapy adherence and rationalize second-line switches in Swaziland. J Int AIDS Soc. 2018;21(10):e25194.","journal-title":"J Int AIDS Soc"},{"issue":"7","key":"14039_CR41","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/INF.0000000000001866","volume":"37","author":"A Bucek","year":"2018","unstructured":"Bucek A, Leu C-S, Benson S, Warne P, Abrams EJ, Elkington KS, et al. Psychiatric disorders, antiretroviral medication adherence and viremia in a cohort of perinatally HIV-infected adolescents and young adults. Pediatr Infect Dis J. 2018;37(7):673\u20137.","journal-title":"Pediatr Infect Dis J"},{"key":"14039_CR42","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1007\/s10461-019-02613-6","volume":"23","author":"RH Gokhale","year":"2019","unstructured":"Gokhale RH, Weiser J, Sullivan PS, Luo Q, Shu F, Bradley H. Depression prevalence, antidepressant treatment status, and association with sustained HIV viral suppression among adults living with HIV in care in the United States, 2009\u20132014. AIDS Behav. 2019;23:3452\u20139.","journal-title":"AIDS Behav"},{"issue":"8","key":"14039_CR43","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1080\/09540121.2012.668174","volume":"24","author":"CA Mellins","year":"2012","unstructured":"Mellins CA, Elkington KS, Leu C-S, Santamaria EK, Dolezal C, Wiznia A, et al. Prevalence and change in psychiatric disorders among perinatally HIV-infected and HIV-exposed youth. AIDS Care. 2012;24(8):953\u201362.","journal-title":"AIDS Care"},{"key":"14039_CR44","unstructured":"MOH. national-guidelines-for-comprehensive-hiv-prevention-care-and-treatment. 2022."},{"issue":"1","key":"14039_CR45","doi-asserted-by":"publisher","first-page":"e068792","DOI":"10.1136\/bmjopen-2022-068792","volume":"13","author":"H Berihun","year":"2023","unstructured":"Berihun H, Bazie GW, Beyene A, Zewdie A, Kebede N. Viral suppression and associated factors among children tested for HIV viral load at Amhara Public Health Institute, Dessie Branch, Ethiopia: a cross-sectional study. BMJ open. 2023;13(1):e068792.","journal-title":"BMJ open"},{"key":"14039_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-06722-3","volume":"21","author":"SB Abdullahi","year":"2021","unstructured":"Abdullahi SB, Ibrahim OR, Okeji AB, Yandoma RI, Bashir I, Haladu S, et al. Viral suppression among HIV-positive patients on antiretroviral therapy in northwestern Nigeria: an eleven-year review of tertiary care centre records, January 2009\u2013December 2019. BMC Infect Dis. 2021;21:1\u20138.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"14039_CR47","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/hiv.13485","volume":"24","author":"HO Abimiku Al, Ramadhani","year":"2023","unstructured":"Abimiku Al, Ramadhani HO, Moloney M, Stafford KA, Chang JCW, Patel HK, et al. Factors associated with viral suppression among adults living with HIV on antiretroviral therapy in Nigeria: Analysis of a population-based survey, 2018. HIV Med. 2023;24(7):827\u201337.","journal-title":"HIV Med"},{"key":"14039_CR48","volume-title":"Barriers to viral load suppression among HIV-positive adolescents in antiretroviral therapy","author":"SE Mushy","year":"2022","unstructured":"Mushy SE, Mtisi E, Mkawe S, Mboggo E, Ndega J, Yahya-Malima KI, et al. Barriers to viral load suppression among HIV-positive adolescents in antiretroviral therapy. Tanzania: a retrospective cohort study in Tanga; 2022."},{"key":"14039_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-018-5964-x","volume":"18","author":"E Nasuuna","year":"2018","unstructured":"Nasuuna E, Kigozi J, Babirye L, Muganzi A, Sewankambo NK, Nakanjako D. Low HIV viral suppression rates following the intensive adherence counseling (IAC) program for children and adolescents with viral failure in public health facilities in Uganda. BMC Public Health. 2018;18:1\u20139.","journal-title":"BMC Public Health"},{"issue":"1","key":"14039_CR50","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1186\/s12879-021-06862-6","volume":"21","author":"Z Lukyamuzi","year":"2021","unstructured":"Lukyamuzi Z, Etajak S, Katairo T, Mukunya D, Tetui M, Ssenyonjo A, et al. Effect and implementation experience of intensive adherence counseling in a public HIV care center in Uganda: a mixed-methods study. BMC Infect Dis. 2021;21(1):1168.","journal-title":"BMC Infect Dis"},{"key":"14039_CR51","doi-asserted-by":"crossref","unstructured":"Leplingard F, Borne S, Martinelli C, Lecl\u00e8re C, Lopez T, Gu\u00e9rin J, et al. editors. FWM-assisted Raman laser for second-order Raman pumping. Optical Fiber Communication Conference; 2003: Optica Publishing Group.","DOI":"10.1109\/OFC.2003.315935"},{"key":"14039_CR52","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2147\/IDR.S341392","volume":"15","author":"GT Atnafu","year":"2022","unstructured":"Atnafu GT, Moges NA, Wubie M, Gedif G. Incidence and Predictors of Viral Load Suppression After Enhanced Adherence Counseling Among HIV-Positive Adults in West Gojjam Zone, Amhara Region, Ethiopia. Infect Drug Resist. 2022;15:261\u201374.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"14039_CR53","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12981-021-00391-7","volume":"18","author":"EF Okonji","year":"2021","unstructured":"Okonji EF, van Wyk B, Mukumbang FC, Hughes GD. Determinants of viral suppression among adolescents on antiretroviral treatment in Ehlanzeni district, South Africa: a cross-sectional analysis. AIDS Res Ther. 2021;18(1):66.","journal-title":"AIDS Res Ther"},{"key":"14039_CR54","doi-asserted-by":"publisher","first-page":"117863372097063","DOI":"10.1177\/1178633720970632","volume":"13","author":"P Wakooko","year":"2020","unstructured":"Wakooko P, Gavamukulya Y, Wandabwa JN. Viral load Suppression and Associated Factors among HIV Patients on Antiretroviral Treatment in Bulambuli District, Eastern Uganda: A Retrospective Cohort Study. Infect Dis (Auckl). 2020;13:1178633720970632.","journal-title":"Infect Dis (Auckl)"},{"key":"14039_CR55","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.2147\/IDR.S393456","volume":"16","author":"JS Mundamshimu","year":"2023","unstructured":"Mundamshimu JS, Malale K, Kidenya BR, Gunda DW, Bwemelo L, Mwashiuya M, et al. Failure to Attain HIV Viral Suppression After Intensified Adherence Counselling-What Can We Learn About Its Factors? Infect Drug Resist. 2023;16:1885\u201394.","journal-title":"Infect Drug Resist"},{"issue":"7","key":"14039_CR56","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s10461-024-04299-x","volume":"28","author":"A Wynn","year":"2024","unstructured":"Wynn A, Sileo KM, Schmarje Crockett K, Naigino R, Ediau M, Menzies NA, et al. Associations Between Alcohol Use, Antiretroviral Therapy Use, and Viral Load Suppression Among People Living with HIV in Rural Central Uganda. AIDS Behav. 2024;28(7):2205\u201315.","journal-title":"AIDS Behav"},{"issue":"11","key":"14039_CR57","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1007\/s10461-021-03263-3","volume":"25","author":"B Myers","year":"2021","unstructured":"Myers B, Lombard C, Joska JA, Abdullah F, Naledi T, Lund C, et al. Associations between patterns of alcohol use and viral load suppression amongst women living with HIV in South Africa. AIDS Behav. 2021;25(11):3758\u201369.","journal-title":"AIDS Behav"},{"issue":"11","key":"14039_CR58","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1080\/17425255.2020.1814737","volume":"16","author":"N Desai","year":"2020","unstructured":"Desai N, Burns L, Gong Y, Zhi K, Kumar A, Summers N, et al. An update on drug\u2013drug interactions between antiretroviral therapies and drugs of abuse in HIV systems. Expert Opin Drug Metab Toxicol. 2020;16(11):1005\u201318.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"14039_CR59","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1186\/s12879-025-10872-z","volume":"25","author":"LD Hlophe","year":"2025","unstructured":"Hlophe LD, Shumba CS, Bedada DT, Nyasulu PS. Determinants of viral load suppression among adolescents on antiretroviral therapy in Eswatini: a cross-sectional study. BMC Infect Dis. 2025;25(1):493.","journal-title":"BMC Infect Dis"},{"key":"14039_CR60","unstructured":"FMOH. National_HIV_Prevention,_care_&_treatment_participant_manual. 2023."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14039-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14039-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14039-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:51:26Z","timestamp":1788864686000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-14039-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14039"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-14039-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5003439\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"30 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical clearance was obtained from Institutional Review Board (IRB) of the Asrat Woldeyes Health Science campus, Debre Berhan University with a\n                      protocol number 204 and reference number IRB 01\/10\/2016 E.C.\n                      In addition, official letters from the city health department were written to the public health facilities for an effective approach in data collection process. Permission granted from the health institutions for accessing all records. The study participants were not directly contacted. This research used secondary data, and performed according to the Helsinki Declaration of no harm. The information from their private record were used only for the study purpose. Data obtained from them were kept confidentially by using codes instead of using personal identifiers.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1619"}}